Lagaud, G. J. L., V. Randriamboavonjy, G. Roul, J. C. Stoclet, and R. Andriantsitohaina. Mechanism of Ca 2ϩ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H300-H308, 1999.-The intracellular Ca 2ϩ stores and the mechanisms of Ca 2ϩ entry produced by norepinephrine (NE) were investigated in small mesenteric resistance arteries of the rat. In Ca 2ϩ -free medium, NE (10 µM) elicited a transient increase in both intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and tension that were both drastically reduced by caffeine and only partially reduced by the two sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) blockers thapsigargin and cyclopiazonic acid, despite the presence of SERCA2a and SERCA2b isoforms in the medial smooth muscle layer of the artery. After depletion of intracellular Ca 2ϩ stores with 10 µM NE, addition of exogenous CaCl 2 (2.5 mM) produced large and sustained increases in both [Ca 2ϩ ] i and contraction of the arteries provided that the agonist was continuously present. In these conditions, the responses to CaCl 2 were inhibited by the voltage-dependent Ca 2ϩ entry blocker nitrendipine (1 µM), the putative inhibitor of receptoroperated Ca 2ϩ entry SKF-96365 (30 µM), and NiCl 2 (1 mM). The inhibition produced by SKF-96365 and NiCl 2 was greater than that of nitrendipine. Also, the responses to CaCl 2 were greatly reduced or abolished in the presence of the Na ϩ /Ca 2ϩ exchanger inhibitors 1,3-dimethyl-2-thiourea, 3Ј,4Ј-dichlorobenzamil, MgCl 2 , and amiloride or after omission of NaCl in the medium. Also, protein kinase C inhibitors, calphostin C and staurosporine, and tyrosine kinase inhibitors, genistein and tyrphostin 23, both reduced the responses to CaCl 2 . The inhibitory effect of protein kinase C inhibitor and tyrosine kinase were additive. These results suggest that NE releases Ca 2ϩ from intracellular stores that are caffeine sensitive and partially sensitive to SERCA inhibitors. They indicate that in addition to Ca 2ϩ influx via nitrendipine-sensitive and SKF-96365-sensitive channels, Na ϩ /Ca 2ϩ exchanger participates in the CaCl 2 -induced contraction produced in NE-exposed vessels. The pathway leading to Ca 2ϩ entry probably involves tyrosine kinase and protein kinase C. All the above mechanisms require ongoing receptor stimulation. calcium entry; intracellular calcium stores IT IS WELL ESTABLISHED that the contractile response to a number of agonists including norepinephrine (NE) comprises two distinct components in Ca 2ϩ -containing medium: an initial phasic component that results from the inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ]-mediated release of Ca 2ϩ from intracellular Ca 2ϩ stores followed by a tonic component that requires Ca 2ϩ entry in the continuous presence of the agonist,
IT IS WELL ESTABLISHED that the contractile response to a number of agonists including norepinephrine (NE) comprises two distinct components in Ca 2ϩ -containing medium: an initial phasic component that results from the inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ]-mediated release of Ca 2ϩ from intracellular Ca 2ϩ stores followed by a tonic component that requires Ca 2ϩ entry in the continuous presence of the agonist, due to Ca 2ϩ influx (4) .
Despite the existence of a large body of literature exploring the roles of Ca 2ϩ influx and release from intracellular stores in the vasoconstriction induced by agonists, the relative contribution of each of these mechanisms is still under debate. In vascular smooth muscle, it seems that the mechanisms of Ca 2ϩ release triggering contraction may vary between vascular beds and with the stimulus. For example, in the rat portal vein, one of the two characterized Ca 2ϩ stores is sensitive to caffeine [an opener of ''Ca 2ϩ -induced Ca 2ϩ release'' ryanodine-sensitive channels (CICR)], whereas both of them are sensitive to Ins(1,4,5)P 3 (33) . Conversely, only one of the two Ca 2ϩ stores characterized in the dog mesenteric artery is released by Ins(1,4,5)P 3 , whereas the other is mobilized by Ca 2ϩ (22) . These observations suggest differential involvement of CICR and Ins(1,4,5)P 3 -sensitive Ca 2ϩ release channels and associated stores.
Ca 2ϩ influx across the plasma membrane generally involves voltage-operated channels and the so-called ''capacitative entry pathway'' activated by store depletion (10) . However, the signaling mechanism for Ca 2ϩ entry via the latter pathway is complex and may also be different depending on the cell type. A number of mediators have been proposed to be implicated for this phenomenon, although no such mediator has been unequivocally demonstrated as yet. These mediators included inositol 1,3,4,5-tetrakisphosphate (17) , small G proteins (5), a ''Ca 2ϩ -influx factor,'' a small phosphate containing nonprotein compound (30) , cytochrome P-450, or one of their products (2) . Finally, a role for tyrosine kinase has been proposed in activation of the capacitative Ca 2ϩ entry (16) .
All of the above findings suggest that agonist stimulation may activate more than one Ca 2ϩ entry pathway that may be different depending on the cell type. In resistance vessels, the presence of both ryanodine-and Ins(1,4,5)P 3 -sensitive Ca 2ϩ release mechanisms has been characterized in the rat small mesenteric artery (32) . However, the involvement of these two mechanisms in NE-induced contraction and the relationship between Ca 2ϩ store depletion and Ca 2ϩ entry is unknown.
The aim of the present study is to further characterize the intracellular Ca 2ϩ stores released by NE and to investigate the mechanism of Ca 2ϩ entry during the The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. tonic contraction produced by this agonist in the small mesenteric resistance artery of the rat, using different pharmacological agents active on the different pathways possibly involved.
METHODS
Arterial preparation and mounting. Male Wistar rats (250-350 g) bred in our institute were killed by cervical dislocation and exsanguinated by carotid artery transection. The viscera were exposed, and a proximal segment of the small bowel was removed and pinned in a dissecting dish containing physiological salt solution (PSS) of the following composition (in mM): 119 NaCl, 4.7 KCl, 0.4 KH 2 PO 4 , 14.9 NaHCO 3 , 1.17 MgSO 4 , 2.5 CaCl 2 , and 5.5 glucose. In Ca 2ϩ -free PSS, Ca 2ϩ was omitted and 1 mM EGTA was added. Branch II or III resistance arteries were cleaned of fat and connective tissue, and a segment 2 mm long was removed. The segment was then mounted in a myograph (as previously described in Ref.
3) filled with PSS continuously kept at 37°C and gassed with a mixture of 95% O 2 -5% CO 2 (pH 7.4). Briefly, two tungsten wires (30 µm diam) were inserted through the lumen of the vessel. Mechanical activity was recorded isometrically by a force transducer (Kistler-Morse, DSG BE4) connected to one of the two tungsten wires, the other being attached to a support carried by a micromanipulator.
After being set up, the vessel was equilibrated for 30 min before being passively stretched to an internal diameter that yields a circumference equivalent to 90% of that given by an internal pressure of 100 mmHg, which requires a load of ϳ200 mg. The internal diameter of the vessels used in this study ranged between 150 and 200 µm. After the vessel was set to its working length, it was challenged twice with 10 µM NE to elicit reproducible contractile responses. All the experiments were carried out on vessels without endothelium. The endothelium was removed by intraluminal perfusion with 0.5% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) for 30 s. The presence of functional endothelium was assessed in all preparations by the ability of acetylcholine (1 µM) to induce relaxation of vessels precontracted with NE (10 µM).
Contraction experiments. In the present study, NE was used throughout the experiments at a concentration (10 µM) giving the maximal contractile response in small mesenteric artery of the rat.
To study the component of NE-induced contraction due to internal Ca 2ϩ release, three intracellular Ca 2ϩ mobilizing agents were used at their maximally active concentrations on rat mesenteric resistance arteries as described previously by Lagaud et al. (19) . These agents were thapsigargin (1 µM) and cyclopiazonic acid (20 µM), two inhibitors of the sarco(endo)plasmic reticulum Ca 2ϩ -ATPases (SERCA), and caffeine (10 mM), an activator of the CICR. These experiments were performed in Ca 2ϩ -free PSS. The tissue was left 20 min in Ca 2ϩ -free PSS before the start of the experiment. The intracellular Ca 2ϩ stores were loaded with Ca 2ϩ by stimulating the vessels with a depolarizing solution, i.e., 100 mM KCl-PSS containing 2.5 mM CaCl 2 in which KCl was substituted for an equimolar amount of NaCl. Thapsigargin and cyclopiazonic acid were preincubated for 20 min before the addition of NE.
To study the mechanisms involved in the Ca 2ϩ entry after store depletion induced by NE, the vessels were challenged with 10 µM NE in Ca 2ϩ -free medium containing 1 mM EGTA. After 20 min, exogenous CaCl 2 (2.5 mM) was added in the bath in the continuous presence of the agonist. The same experimental condition was used in the absence and presence of different pharmacological agents. A washout period of 30 min was allowed between each experimental protocol.
Ca 2ϩ entry blockers were used at their maximally active concentrations, being 1 µM for the voltage-operated Ca 2ϩ channel blocker nitrendipine, 30 µM for the reported receptormediated Ca 2ϩ entry blocker SKF-96365 (1-5␤-[3-(p-methoxyphenyl)-propyloxyl]-p-methoxyphenethyl6-1H-imidazole hydroxy chloride) (21) , and 1 mM for the inorganic Ca 2ϩ channel blocker NiCl 2 .
Four inhibitors of the Na ϩ /Ca 2ϩ exchanger were also used: 1,3-dimethyl-2-thiourea (DMTU) at 25 mM, 3Ј,4Ј-dichlorobenzamil (DCB) at 10 µM, MgCl 2 at 10 mM, and amiloride at 1 mM, as described previously (20, 34) . In some vessels, experiments were performed in PSS in which NaCl was omitted and replaced with an equimolar amount of choline chloride.
The involvement of different protein kinases in the mechanism of Ca 2ϩ entry was tested using the tyrosine kinase inhibitors genistein (30 µM) and tyrphostin 23 (100 µM) and the protein kinase C inhibitors staurosporine (30 nM) and calphostin C (1 µM). All the inhibitors were used at their maximally active concentrations and were preincubated 30 min before activation by NE (10 µM).
Measurement of intracellular Ca 2ϩ . Simultaneous measurement of intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and contraction were performed to study the relationships between Ca 2ϩ stores, Ca 2ϩ entry, and the contraction induced by NE in small mesenteric arteries. Changes in [Ca 2ϩ ] i were determined by measuring the fluorescence of trapped fura 2 with a dual-excitation wavelength fluorometer (Fluorolog II, SPEX, Edison, NJ) as described by Andriantsitohaina et al. (3) . The vessel segments were loaded over a 2-h period with fura 2 by incubation in the dark in PSS containing both 5 µM fura 2-AM and 2% pluronic acid. The tissue was then returned to the chamber and washed three times with PSS (37°C) to remove excess external fura 2-AM. The experiments were performed in PSS (37°C) continuously gassed with 95% O 2 -5% CO 2 (pH 7.4). At the end of each experiment, the Ca 2ϩ signal was calibrated using ionomycin (20 µM), NE (10 µM), and CaCl 2 (5 mM) for the maximal fluorescence and 20 mM EGTA in Ca 2ϩ -free solution for the minimal fluorescence. The ratio of fluorescence of the emission of fura 2 was obtained at 510 nm and was calculated after subtraction of the autofluorescence at 340 and 380 nm. Background fluorescence and autofluorescence were measured by looking at the fluorescence of the vessel without the dye at 510 nm after its excitation at 340 and 380 nm.
Immunofluorescence labeling of SERCA2a and SERCA2b. Segments of rat small mesenteric arteries were immersed in freshly prepared 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 6 h. They were then soaked overnight in buffer containing 20% sucrose. The samples were then frozen in cooled isopentane (Ϫ50°C) and sectioned on a cryostat microtome; 12-µm-thick sections were flow-mounted on gelatin-coated slides. The sections were then processed with the conventional indirect immunofluorescence technique. The antibodies used were the SERCA2a and SERCA2b isoform-specific polyclonal antibodies elicited in rabbits against peptides encompassing the 12 COOH-terminal amino acids (1031-1042) of SERCA2b and 9 COOH-terminal amino acids (989-997) of SERCA2a. The preparation and specificity of these antibodies have both been previously described (35) . The antibodies against SERCA2a and SERCA2b were diluted 1:50 in 0.05 M phosphate-buffered 0.9% saline, pH 7.3, containing 0.5% Triton X-100. The primary antibodies were applied overnight at 4°C. The secondary antibody was the FITC-labeled anti-rabbit IgG (Biosys, France). FITC-labeled sections were coverslipped in polyvinyl alcohol mounting All results are expressed as means Ϯ SE of n experiments. ANOVA was used for statistical analysis. Means were considered significantly different when the P value was Ͻ0.05.
Drugs. Acetylcholine chloride, caffeine, CHAPS, cyclopiazonic acid, DMTU, genistein, MgCl 2 , NE bitartrate, NiCl 2 , thapsigargin, tyrphostin 23, and staurosporine were purchased from Sigma (Grenoble, France). Calphostin C and ryanodine were purchased from Calbiochem (France). Fura 2-AM was purchased from Molecular Probes (Eugene, OR). DCB was a generous gift from Dr. C. Frelin (Nice, France). Nitrendipine was a generous gift from Bayer (Paris, France). SKF-96365 was a generous gift from SmithKline Beecham Pharmaceuticals (London, UK). SERCA2a and SERCA2b were a generous gift from Dr. F. Wuytack (Katholieke Universiteit Leuven, Belgium). Nitrendipine was dissolved in absolute ethanol. Calphostin C, DCB, and thapsigargin were dissolved in dimethyl sulfoxide (1 mg/ml), and the final concentration of dimethyl sulfoxide in the bath was 0.1%. Genistein, tyrphostin 23, and staurosporine were dissolved in dimethyl sulfoxide, and the maximal concentration of dimethyl sulfoxide in the bath was 1.2% for 100 µM tyrphostin 23. All other drugs were diluted in deionized water (Q10, Millipore).
RESULTS
Acetylcholine was not able to produce relaxation in vessels precontracted with NE after endothelium denudation with CHAPS. Also, the latter procedure resulted in a 10-fold increase in sensitivity to NE, the EC 50 values being reduced from 1.01 Ϯ 0.01 µM (n ϭ 90) to 0.101 Ϯ 0.01 µM (n ϭ 62; P Ͻ 0.001). Maximal peak response obtained with 10 µM NE was not significantly different in vessels with and without functional endothelium [1.53 Ϯ 0.48 g (n ϭ 90) and 1.14 Ϯ 0.47 g (n ϭ 62), respectively]. These data show that the use of CHAPS to functionally denude the endothelium removed the inhibitory effect of the endothelium without significantly altering the contractile function of the vessel.
Characterization of intracellular stores released by NE. Immunostainings using specific antibodies for SERCA2a and SERCA2b isoforms were performed to assess the presence and distribution of SERCA isoforms in different layers of the vessels (Fig. 1) . SERCA2a (Fig. 1A) and SERCA2b (Fig. 1B) stainings were observed in the endothelial and in the medial layers of the vessels. No staining was observed in negative controls performed in vessels in the absence of SERCA2a and SERCA2b antibodies (Fig. 1C) .
In Ca 2ϩ -free medium, NE produced a fast transient increase in both [Ca 2ϩ ] i and tension (Fig. 2) . In the same condition, caffeine also elicited a fast transient increase in [Ca 2ϩ ] i and tension and drastically reduced a subsequent response to NE. It should be noted that in the same condition, the inhibitor of CICR, ryanodine (10 µM), did not elicit contraction but prevented a subsequent response to NE (Fig. 2B) . Also in Ca 2ϩ -free medium, thapsigargin alone did not induce any change in [Ca 2ϩ ] i and tension, but it reduced the increase in [Ca 2ϩ ] i and the contractile response subsequently induced by NE (Fig. 2) . Similar results were obtained with another inhibitor of SERCA, cyclopiazonic acid, used under the same experimental conditions (Fig. 2B) . The caffeine response was not affected by prior stimulation with thapsigargin or cyclopiazonic acid, but it was prevented by NE.
Mechanisms of Ca 2ϩ entry after depletion of intracellular stores with NE. None of the pharmacological agents used significantly affected the contraction produced by NE in Ca 2ϩ -free medium except DCB (Table 1) .
When added after both [Ca 2ϩ ] i and tension had returned to the baseline, CaCl 2 elicited a large and sustained rise in both [Ca 2ϩ ] i and contraction that was reduced by 50% by nitrendipine and significantly more inhibited by SKF-96365 (76%) and NiCl 2 (74%) (Fig. 3) . Under the same experimental conditions, no responses were observed after addition of CaCl 2 when caffeine, thapsigargin, or cyclopiazonic acid was used instead of NE (data not shown).
The effect of the Na ϩ /Ca 2ϩ exchange inhibitors DMTU and amiloride on the increase in both [Ca 2ϩ ] i and contraction produced by CaCl 2 has been studied in NE-exposed vessels after depletion of intracellular stores (Fig. 4) . Both responses were reduced by DMTU and drastically reduced by amiloride. It should be noted that DMTU and amiloride did not produce any rise in [Ca 2ϩ ] i and contraction when added to unstimulated vessels. Also as shown in Fig. 4 , the other inhibitors of http://ajpheart.physiology.org/ Na ϩ /Ca 2ϩ exchange, DCB and MgCl 2 , greatly reduced or abolished the contraction produced by CaCl 2 in NE-exposed vessels after depletion of intracellular stores. The rank order of efficacy of these inhibitors was DMTU Ͻ DCB Ͻ MgCl 2 ϭ amiloride. Also, omission of NaCl in the PSS and its replacement with choline did not produce any rise in [Ca 2ϩ ] i and contraction but abolished the contractile response to CaCl 2 . It should be noted that nitrendipine reduced the DMTU-insensitive response to CaCl 2 , and SKF-96365 abolished this response. The responses to CaCl 2 in NE-exposed vessels were 99 Ϯ 2.2, 47 Ϯ 4.5, 10 Ϯ 0.9, and 2 Ϯ 1.3% (n ϭ 5) in the absence and presence of DMTU, DMTU plus nitrendipine, and DMTU plus SKF-96365, respectively.
The tyrosine kinase inhibitor genistein reduced the increases in both [Ca 2ϩ ] i and contraction produced by CaCl 2 in vessels that had previously been depleted with NE (Fig. 5) . The mean of CaCl 2 -induced contractile force was significantly decreased by genistein and tyrphostin 23. In the presence of either genistein or tyrphostin 23, nitrendipine failed to inhibit further CaCl 2 -induced contraction elicited by NE.
The effect of the protein kinase C inhibitor staurosporine on the increase in both [Ca 2ϩ ] i and contraction produced by CaCl 2 has been studied in NE-exposed vessels after depletion of intracellular stores (Fig. 6) . Staurosporine reduced the increases in both [Ca 2ϩ ] i and contraction produced by CaCl 2 in NE-exposed arteries. The exogenous CaCl 2 -induced contractile response of NE exposed vessels was also significantly reduced by another protein kinase C inhibitor, calphostin C (Fig.  6) . The inhibitory effects of genistein and staurosporine or genistein and calphostin C on the CaCl 2 -induced contraction elicited by NE were additive (Fig. 6) , suggesting that tyrosine kinase inhibition and protein kinase C inhibition decreased the CaCl 2 -induced contractile response of NE-exposed vessels through different pathways.
DISCUSSION
The above results characterize intracellular stores from which Ca 2ϩ are released by NE and the mechanisms of Ca 2ϩ entry triggered by the agonist in rat http://ajpheart.physiology.org/ small mesenteric artery smooth muscle cells. One major finding is that, in NE exposed arteries, tonic contraction induced by the addition of CaCl 2 after depletion of Ca 2ϩ stores involved the Na ϩ /Ca 2ϩ exhanger in addition to Ca 2ϩ entry through both dihydropyridine-and SKF-96365-sensitive mechanisms. In addition, the data obtained with inhibitors support the involvement of both tyrosine kinase and protein kinase C in Ca 2ϩ entry elicited by NE. All of the above mechanisms required the continuous presence of the agonist.
The results indicate that the release of Ca 2ϩ induced by NE takes place at the level of an intracellular Ca 2ϩ store that can also be mobilized by caffeine and ryanodine.
Two SERCA inhibitors, thapsigargin and cyclopiazonic acid, with different chemical structures, were used at concentrations that are able to cause a rapid increase in [Ca 2ϩ ] i and to empty Ca 2ϩ stores in other vascular smooth muscle cells (9) and vessels (23, 27) . Despite the presence in the medial layer of the two SERCA isoforms (SERCA2a and SERCA2b), which are generally found in vascular smooth muscle cells and are inhibited by both thapsigargin and cyclopiazonic acid (21), both drugs failed to increase [Ca 2ϩ ] i and tension in rat small mesenteric arteries. It cannot be ruled out that both thapsigargin and cyclopiazonic acid did not reach the SERCA at sufficient concentrations to entirely inhibit them, although this is unlikely because the small mesenteric arteries are much thinner than other vessels like the aorta. It is possible that the fura 2 probe could not detect local increase in [Ca 2ϩ ] i produced by SERCA inhibitors in the absence of any signal inducing sufficient Ca 2ϩ release (31) . However, the data reported above suggest that NE induced the release of Ca 2ϩ from two storage compartments in small mesenteric arteries smooth muscle cells, one of them being sensitive to thapsigargin and cyclopiazonic acid, and both of them can be depleted by the CICR reagents caffeine and ryanodine. This interpretation is consistent with the recent finding that a thapsigargin-insensitive Ca 2ϩ pool is present in a subcompartment of the endoplasmic reticulum in different mammalian cells (29) . In addition, the presence of SERCA2a and SERCA2b in the endothelium layer of small mesenteric arteries found in the present study is consistent with previously reported endothelium-dependent relaxation elicited by SERCA inhibitors in these vessels (11) .
In general, depletion of Ca 2ϩ stores is believed to induce the so-called capacitative Ca 2ϩ entry. This phenomenon has been described in a vascular muscle cell line (A7r5) after store depletion by thapsigargin or by an agonist, vasopressin (7). It probably results from Ca 2ϩ release activated current described in various cells (10) . The activation of this current relies on store depletion, but it does not require the continuous presence of the agonist (10) . The ionic channels involved in the so-called capacitative Ca 2ϩ entry have been studied in rat aorta (26) . It was found that Ca 2ϩ entry occurred through a cromakalim-and dihydropyridine-sensitive Ca 2ϩ channel after store depletion by a mechanism independent of the presence of the agonist. In contrast, the continuous presence of NE was necessary, in rat small mesenteric arteries, for the increase in [Ca 2ϩ ] i and contraction elicited by the addition of CaCl 2 after store depletion. It has been reported that SKF-96365 is able to inhibit Ca 2ϩ release activated current (10); however, because this drug also inhibits dihydropyridine-sensitive Ca 2ϩ channels, as discussed below, its effect is not specific to Ca 2ϩ entry through the capacitative entry route.
After depletion of the stores, the increases in [Ca 2ϩ ] i and contraction induced by CaCl 2 in NE-exposed arteries were reduced by the dihydropyridine Ca 2ϩ entry blocker nitrendipine and by a drug which can inhibit both voltage-operated and receptor-operated Ca 2ϩ channels, SKF-96365 (19, 24) . It should be noted that the inhibitory effect of SKF-96365 was greater than that of nitrendipine, whereas the latter was not able to produce further inhibition in the presence of SKF-96365. Thus, after Ca 2ϩ store depletion, NE stimulates Ca 2ϩ entry mainly through both voltage-dependent Ca 2ϩ channels sensitive to nitrendipine. In accordance with data reported in the literature obtained in the same type of artery, voltage-dependent Ca 2ϩ channels appear to play a significant role in the regulation of [Ca 2ϩ ] i in these vessels (25) . Also, the above data showed that NE might stimulate the so-called receptor-operated channels sensitive to SKF-96365. This conclusion is consistent with the dual effect of SKF-96365 on the Ca 2ϩ entry through inhibition of the opening of both receptoroperated and voltage-operated Ca 2ϩ channels in rat small resistance arteries previously described by Lagaud et al. (19) in the case of ATP. It is reinforced by the finding that nonselective blockade of Ca 2ϩ channels by high concentration of NiCl 2 (known to produce nonselective Ca 2ϩ channels blockade) reduced the responses to CaCl 2 of NE-exposed vessels to the same extent as that observed in the presence of SKF-96365.
The hypothesis that another possible route for Ca 2ϩ entry into vascular smooth muscle cells via the Na ϩ /Ca 2ϩ exchanger has also been tested here. The extracellular CaCl 2 -induced responses on NE-exposed mesenteric arteries were abolished when extracellular Na ϩ was omitted from PSS. Also, the CaCl 2 -induced increase in [Ca 2ϩ ] i and contraction produced by NE were greatly reduced or abolished by the Na ϩ /Ca 2ϩ exchange inhibitors DMTU and DCB or MgCl 2 and amiloride, respectively. Moreover, the DMTU-insensitive component of the CaCl 2 -induced responses was reduced or abolished by nitrendipine or SKF-96365, respectively. The reported specific inhibitor of the Na ϩ /Ca 2ϩ exchanger, DCB, at a concentration below the IC 50 values at which it suppressed the inward Na ϩ /Ca 2ϩ exchange current in cardiac ventricular cell (34) , also reduced the extracellular CaCl 2 -induced responses on NE-exposed vessels. Taken together, these data show that extracellular Na ϩ is needed for the CaCl 2 -induced responses, and they indicate that the Na ϩ /Ca 2ϩ exchanger may contribute to the pathway leading to Ca 2ϩ entry produced by NE. Such observations are consistent with previous reports showing that NE or KCl, by depolarizing the cells, produces a rise in intracellular Na ϩ that thereby activates a reverse mode of the Na ϩ /Ca 2ϩ exchanger, leading to an increase of Ca 2ϩ influx in vascular smooth muscle cells in addition to the opening of Ca 2ϩ channels (18) . Also, the present results are consistent with those reported in the literature showing the presence of the Na ϩ /Ca 2ϩ exchanger as a viable mechanism for Ca 2ϩ transport in other cell types such as the endothelium of http://ajpheart.physiology.org/ rabbit cardiac valve, in which the Ca 2ϩ entry component is enhanced when intracellular Na ϩ concentration is elevated (20) . Moreover, the present data are in agreement with those reported by Blaustein (6) showing that NE elicited a rise in intracellular Na ϩ concentration (via activation of the Na ϩ /H ϩ exchanger, following its phosphorylation by protein kinase C) and a subsequent reverse mode of Na ϩ /Ca 2ϩ exchange operation. Indeed, we found here that the protein kinase C inhibitors staurosporine and calphostin C reduced the CaCl 2 -induced responses on NE-exposed vessels. However, it is difficult to determine the exact intracellular target of protein kinase C on the CaCl 2 -induced responses on NE-exposed vessels, inasmuch as its role in agonist-induced contraction is not essential in rat mesenteric small arteries (28) . Nevertheless, the present results suggest that the Na ϩ /Ca 2ϩ exchange may participate in the increase of [Ca 2ϩ ] i and contraction produced by CaCl 2 in NE-exposed vessels after depletion of intracellular stores. Finally, the fact that nitrendipine reduced the DMTU-insensitive response to CaCl 2 and SKF-96365 abolished this response reinforce the hypothesis that the Ca 2ϩ entry produced by NE is composed of two parts, activation of voltage-dependent Ca 2ϩ channels and receptor-dependent Ca 2ϩ channels sensitive to SKF-96365.
There is evidence that tyrosine kinases participate in the regulation of Ca 2ϩ entry associated with agonistinduced contraction in smooth muscle cells (16) . In the present study, we used two groups of tyrosine kinase inhibitors, a compound interacting with the ATP binding site of the enzyme, genistein, and a compound that interacts with the substrate binding site of the enzyme, tyrphostin 23. Both tyrosine kinase inhibitors reduced the CaCl 2 -induced increase in [Ca 2ϩ ] i and the resultant contraction in NE-exposed vessels. Although the inhibitory effect of genistein and tyrphostin 23 on tyrosine phosphorylation was not directly assessed in the present study, the properties of these agents at the concentrations used have been previously well documented (1, 13) . Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction have been reported in the literature. These effects include blockade of a step involved in Ca 2ϩ entry and Ca 2ϩ store refilling by the agonist and blockade of the effect of Ca 2ϩ on the contractile apparatus. In the present study, neither genistein nor tyrphostin 23 affected the increase in [Ca 2ϩ ] i and contraction produced by NE in Ca 2ϩ -free medium, suggesting that tyrosine kinase did not play a role in mediating the responses linked to the release of intracellular Ca 2ϩ produced by NE. Furthermore, the inhibitory effects of genistein and staurosporine or genistein and calphostin C on the CaCl 2 -induced responses in NE-exposed vessels were additive, suggesting that tyrosine kinase did not affect the protein kinase C-sensitive component of the contraction associated with the entry of Ca 2ϩ produced by NE. Because nitrendipine did not produce an additional inhibitory effect on the Ca 2ϩ -induced responses on NE-exposed vessels in the presence of either genistein or tyrphostin 23, it is most likely that tyrosine kinase activation by NE modulates the entry of Ca 2ϩ linked to the opening of voltage-dependent Ca 2ϩ channels sensitive to nitrendipine. Tyrosine kinase inhibitors might reduce the Ca 2ϩ -induced responses in vessels exposed to NE at the level of the contractile apparatus. However, neither genistein nor tyrphostin 23 modified significantly responses to KCl depolarization (KCl, 100 mM) in the same arteries. Also, genistein did not significantly affect the response to CaCl 2 (3 µM) on vessels permeabilized with ␤-escin (data not shown). Taken together, these data suggest that tyrosine kinase inhibitors might not mediate their effects through the inhibition of contractile machinery. Also, it should be noted that at the concentrations used, both genistein and tyrphostin 23 have been reported to inhibit tyrosine kinase activity but not other kinases linked to the signal transduction leading to vascular contraction such as myosin light-chain kinase (1, 13) . Therefore, the present study provides pharmacological evidence supporting the involvement of tyrosine kinase in the Ca 2ϩ influx activated by NE-mediated store depletion at the level of dihydropyridine-sensitive Ca 2ϩ entry in rat small resistance arteries.
We cannot exclude that the complexity of the signal transduction involved in the responses to NE might be due to the activation of multiple ␣ 1 -adrenoceptor populations. Indeed, the characterization of ␣ 1 -adrenoceptor population in small resistance arteries shows that NE mainly activates ␣ 1 -adrenoceptor population, which belongs to ␣ 1A -, ␣ 1B -, and the pharmacologically defined ␣ IL -subtypes (8, 12, 33) . Further studies are needed to better understand the nature of the receptor subtypes implicated in the observed different pathways in these arteries.
In summary, the present study shows that NE releases Ca 2ϩ from intracellular stores that are sensitive to caffeine and partially sensitive to SERCA inhibitors. They also suggest that, in addition to the participation of nitrendipine-sensitive and SKF-96365-sensitive channels, the Na ϩ /Ca 2ϩ exchange may contribute to the Ca 2ϩ influx produced by NE after depletion of intracellular stores. Finally, this Ca 2ϩ influx requires ongoing receptor activation and probably involves tyrosine kinase and protein kinase C.
